Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Piper-Vallillo, Andrew
26  Ergebnisse:
Personensuche X
?
1

A Real-World Study of Patient Characteristics and Clinical ..:

Viray, Hollis ; Piper-Vallillo, Andrew J. ; Widick, Page...
Cancers.  16 (2024)  6 - p. 1079 , 2024
Link: https://doi.org/10.3390/..
 
?
2

The ASCENT Trial: a phase 2 study of induction and consolid..:

Chang, Allison E B ; Piper-Vallillo, Andrew J ; Mak, Raymond H...
The Oncologist.  29 (2024)  7 - p. 609-618 , 2024
Link: https://doi.org/10.1093/..
 
?
3

Osimertinib in NSCLC With Atypical EGFR-Activating Mutation..:

Ji, Jingran ; Aredo, Jacqueline V. ; Piper-Vallillo, Andrew...
JTO Clinical and Research Reports.  4 (2023)  3 - p. 100459 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Be..:

White, Maya N. ; Piper-Vallillo, Andrew J ; Gardner, Rebecca M....
Clinical Lung Cancer.  23 (2022)  3 - p. e210-e221 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Complete pathologic response to short-course neoadjuvant al..:

Sentana-Lledo, Daniel ; Viray, Hollis ; Piper-Vallillo, Andrew J....
Lung Cancer.  172 (2022)  - p. 124-126 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Differential Pattern of Resistance and Sensitivity to Diffe..:

Piper-Vallillo, Andrew J. ; Kobayashi, Susumu S. ; Costa, Daniel B.
JTO Clinical and Research Reports.  2 (2021)  3 - p. 100133 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Impact of Cancer History on Outcomes Among Hospitalized Pat..:

Klein, Isaac A. ; Rosenberg, Shoshana M. ; Reynolds, Kerry L....
The Oncologist.  26 (2021)  8 - p. 685-693 , 2021
Link: https://doi.org/10.1002/..
 
?
8

Coronavirus Disease 2019 Infection in a Patient Population ..:

Piper-Vallillo, Andrew J. ; Mooradian, Meghan J. ; Meador, Catherine B....
JTO Clinical and Research Reports.  2 (2021)  1 - p. 100124 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Acquired Resistance to Osimertinib Plus Savolitinib Is Medi..:

Piper-Vallillo, Andrew J. ; Halbert, Brian T. ; Rangachari, Deepa..
JTO Clinical and Research Reports.  1 (2020)  4 - p. 100071 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Heart Failure Associated With the Epidermal Growth Factor R..:

Piper-Vallillo, Andrew J. ; Costa, Daniel B. ; Sabe, Marwa A..
JACC: CardioOncology.  2 (2020)  1 - p. 119-122 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer ..:

Piper-Vallillo, Andrew J. ; Sequist, Lecia V.
JACC: CardioOncology.  1 (2019)  2 - p. 179-181 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Osimertinib in NSCLC With Atypical EGFR-Activating Mutation..:

Ji, Jingran ; Aredo, Jacqueline V ; Piper-Vallillo, Andrew...
qt4t34k587.  , 2023
Link: https://escholarship.org..
 
?
13

Osimertinib in NSCLC With Atypical EGFR-Activating Mutation..:

Ji, Jingran ; Aredo, Jacqueline V ; Piper-Vallillo, Andrew...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984841/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Complete pathologic response to short-course neoadjuvant al..:

Sentana-Lledo, Daniel ; Viray, Hollis ; Piper-Vallillo, Andrew J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719796/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Differential Pattern of Resistance and Sensitivity to Diffe..:

Piper-Vallillo, Andrew J ; Kobayashi, Susumu S ; Costa, Daniel B
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474188/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15